Related Experiment Video

Updated: Jun 13, 2025

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

2.4K

The complexity of immune evasion mechanisms throughout the metastatic cascade

Nicole M Haynes1,2, Thomas B Chadwick1,2, Belinda S Parker3,4

  • 1Cancer Evolution and Metastasis Program, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.

Nature Immunology
|September 16, 2024
PubMed

Insights

Cancer metastasis involves immune escape. This review details how tumor cells adapt and interact with the immune system to spread, highlighting the need for multifaceted strategies to overcome immune suppression and manage metastatic disease.

Area of Science:

  • Oncology
  • Immunology
  • Cell Biology

Background:

  • Metastasis, the spread of cancer, remains a significant clinical challenge.
  • Immune escape mechanisms are critical for tumor cell survival and dissemination during metastasis.
  • Understanding tumor cell plasticity and immune interactions is vital for effective cancer treatment.

Purpose of the Study:

  • To explore immune escape mechanisms throughout the metastatic cascade.
  • To analyze the adaptive plasticity of disseminated tumor cells.
  • To elucidate the role of immune systems in fostering an immunosuppressive tumor microenvironment.

Main Methods:

  • Review of current literature on cancer metastasis and immunology.
  • Analysis of adaptive plasticity in disseminated epithelial tumor cells.
  • Examination of tumor cell-microenvironment interactions and immune system effects.

Main Results:

  • Disseminated tumor cells exhibit adaptive plasticity, undergoing phenotypic transitions to survive.
  • Both innate and adaptive immune systems contribute to an immunosuppressive milieu that promotes metastasis.
  • Immune escape mechanisms are integral to tumor cell dissemination and organotropism.

Conclusions:

  • Managing metastatic disease requires targeting mechanisms that suppress anti-tumor immunity.
  • A comprehensive understanding of tumor-immune interactions is essential for developing new therapeutic strategies.
  • This review provides insights into the complex interplay governing metastatic progression and immune evasion.

More Related Videos

Experimental Metastasis and CTL Adoptive Transfer Immunotherapy Mouse Model08:06

Experimental Metastasis and CTL Adoptive Transfer Immunotherapy Mouse Model

Published on: November 26, 2010

19.5K
Lung Tumor Cell Recruitment Assay04:28

Lung Tumor Cell Recruitment Assay

Published on: February 26, 2019

5.3K

Related Concept Videos

Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.3K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K